Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Drug-induced liver injury (DILI) is a frequent cause of pediatric liver disease; however, the data on DILI are remarkably limited. Methods: All 69 children hospitalized with DILI between January 2009 and December 2011 were retrospectively studied. Results: A total of 37.7% of the children had medical histories of respiratory infection. The clinical injury patterns were as follows: hepatocellular 89.9%, cholestatic 2.9%, and mixed 7.2%. Liver biopsies from 55 children most frequently demonstrated chronic (47.3%) and acute (27.3%) hepatitis. Hypersensitivity features, namely, fever (31.9%), rash (21.7%), and eosinophilia (1.4%), were found. Twenty-four children (34.8%) developed chronic DILI. Antibiotics (26.1%) were the most common Western medicines (WMs) causing DILI, and the major implicated herbs were Ephedra sinica and Polygonum multiflorum. Compared with WM, the children whose injuries were caused by Chinese herbal medicine (CHM) showed a higher level of total bilirubin (1.4 mg/dL vs 16.6 mg/dL, p=0.004) and a longer prothrombin time (11.8 seconds vs 17.3 seconds, p=0.012), but they exhibited less chronic DILI (2/15 vs 18/39, p=0.031). Conclusions: Most cases of DILI in children are caused by antibiotics or CHM used to treat respiratory infection and present with hepatocellular injury. Compared with WM, CHM is more likely to cause severe liver injury, but liver injury caused by CHM is curable.
Abstract
Background/Aims: Drug-induced liver injury (DILI) is a frequent cause of pediatric liver disease; however, the data on DILI are remarkably limited. Methods: All 69 children hospitalized with DILI between January 2009 and December 2011 were retrospectively studied. Results: A total of 37.7% of the children had medical histories of respiratory infection. The clinical injury patterns were as follows: hepatocellular 89.9%, cholestatic 2.9%, and mixed 7.2%. Liver biopsies from 55 children most frequently demonstrated chronic (47.3%) and acute (27.3%) hepatitis. Hypersensitivity features, namely, fever (31.9%), rash (21.7%), and eosinophilia (1.4%), were found. Twenty-four children (34.8%) developed chronic DILI. Antibiotics (26.1%) were the most common Western medicines (WMs) causing DILI, and the major implicated herbs were Ephedra sinica and Polygonum multiflorum. Compared with WM, the children whose injuries were caused by Chinese herbal medicine (CHM) showed a higher level of total bilirubin (1.4 mg/dL vs 16.6 mg/dL, p=0.004) and a longer prothrombin time (11.8 seconds vs 17.3 seconds, p=0.012), but they exhibited less chronic DILI (2/15 vs 18/39, p=0.031). Conclusions: Most cases of DILI in children are caused by antibiotics or CHM used to treat respiratory infection and present with hepatocellular injury. Compared with WM, CHM is more likely to cause severe liver injury, but liver injury caused by CHM is curable.
참고문헌 (40)
- Zhu XX, "Clinical features of drug-induced liver injury in children", Zhongguo Dang Dai Er Ke Za Zhi, 14, pp.131~133 (2012)
- Squires RH Jr, "Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group", J Pediatr, 148, pp.652~658 (2006)
- Murray KF, "Drug-related hepatotoxicity and acute liver failure", J Pediatr Gastroenterol Nutr, 47, pp.395~405 (2008)
- Orostegui L, "Fondaparinux (Arixtra*) hepatotoxicity in a 6 year-old child", J Hepatol, 58, pp.195~198 (2013)
- Okada T, "Nafamostat mesilate-induced hepatocellular necrosis in a child with pancreatitis caused by pancreaticobiliary maljunction: drug-induced liver injury", Pancreas, 41, pp.981~983 (2012)
- Wang SZ, "Clinical characteristics of drug-induced liver injury in 31 pediatric cases", Zhonghua Gan Zang Bing Za Zhi, 20, pp.193~195 (2012)
- Hita EO, "Amoxicillin-clavulanic acid hepatotoxicity in children", J Pediatr Gastroenterol Nutr, 55, pp.663~667 (2012)
- Molleston JP, "Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study", J Pediatr Gastroenterol Nutr, 53, pp.182~189 (2011)
- Johnson TN, "Intestinal metabolism and transport of drugs in children: the effects of age and disease", J Pediatr Gastroenterol Nutr, 47, pp.3~10 (2008)
- Piñeiro-Carrero VM, "Liver", Pediatrics, 113(4), pp.1097~1106 (2004)
- Faa G, "A developmental approach to drug-induced liver injury in newborns and children", Curr Med Chem, 19, pp.4581~4594 (2012)
- Fontana RJ, "Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop", Hepatology, 52, pp.730~742 (2010)
- Wu CH, "The prevalence of herb and dietary supplement use among children and adolescents in the United States: results from the 2007 National Health Interview Survey", Complement Ther Med, 21, pp.358~363 (2013)
- Hepatobiliary Collaborative Group, "Chinese Society of Gastroenterology. National multi-centers survey on inpatients with acute severe drug-induced liver injury", Chin J Dig, 33, pp.80~83 (2013)
- Bunchorntavakul C, "Review article: herbal and dietary supplement hepatotoxicity", Aliment Pharmacol Ther, 37, pp.3~17 (2013)
- Chalasani N, "Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States", Gastroenterology, 135, pp.1924~1934 (2008)
- Devarbhavi H, "Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents", Hepatology, 54, pp.1344~1350 (2011)
- Danan G, "Causality assessment of adverse reactions to drugs: I. a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries", J Clin Epidemiol, 46, pp.1323~1330 (1993)
- Bénichou C, "Criteria of drug-induced liver disorders: report of an international consensus meeting", J Hepatol, 11, pp.272~276 (1990)
- Kleiner DE, "The pathology of drug-induced liver injury", Semin Liver Dis, 29, pp.364~372 (2009)
- Kleiner DE, "Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations", Hepatology, 59, pp.661~670 (2014)
- Rockey DC, "Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method", Hepatology, 51, pp.2117~2126 (2010)
- Rochon J, "Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury", Hepatology, 48, pp.1175~1183 (2008)
- Andrade RJ, "Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period", Gastroenterology, 129, pp.512~521 (2005)
- Hunt CM, "Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review", Hepatology, 52, pp.2216~2222 (2010)
- Ding QY, "The clinical analysis of drug induced hepatitis in child", Jiangsu Med J, 36, pp.339~340 (2010)
- Hayashi PH, "Clinical features, diagnosis, and natural history of drug-induced liver injury", Semin Liver Dis, 34, pp.134~144 (2014)
- Schoepfer AM, "Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products", J Hepatol, 47, pp.521~526 (2007)
- Li FY, "Research status of herbal drug-induced liver injury", Chin J Tradit Chin Med Pharmacol, 24, pp.265~269 (2009)
- Skoulidis F, "Ma huang associated acute liver failure requiring liver transplantation", Eur J Gastroenterol Hepatol, 17, pp.581~584 (2005)
- Liu HC, "The liver damage of herbs and the other botanical herbs", Chin Hepatol, 6, pp.52~53 (2001)
- Liu SM, "Herbal drug-induced liver injury", pp.68~70 (2007), China Press of Traditional Chinese Medicine
- Nam SW, "A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee)", Clin Toxicol, 43, pp.589~591 (2005)
- Dong Y, "Current status on the interaction of cytochrome P450 and metabolism of Chinese materia medica", Chin J Inf Tradit Chin Med, 18, pp.100~103 (2011)
- Guerra MC, "Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism", Life Sci, 67, pp.2997~3006 (2000)
- Björnsson E, "Drug-induced liver injury: Hy’s rule revisited", Clin Pharmacol Ther, 79, pp.521~528 (2006)
- Verma S, "Diagnosis, management and prevention of drug-induced liver injury", Gut, 58, pp.1555~1564 (2009)
- Aithal PG, "The natural history of histologically proved drug induced liver disease", Gut, 44, pp.731~735 (1999)
- Rangnekar AS, "An update on drug induced liver injury", Minerva Gastroenterol Dietol, 57, pp.213~229 (2011)
- Fontana RJ, "Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset", Gastroenterology, 147, pp.96~108 (2014)